Medivir: Intervju med vd Yilmaz Mahshid (video)

Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Medivir: Intervju med vd Yilmaz Mahshid (video)

2021-01-13

11:55

NE

Niklas Elmhammer

Medivir

8.99

▼ 0.04

-0.44%

Premium Plan required to unlock

Redeye tog en pratstund med Medivirs Vd Yilmaz Mahshid efter nyheten om licensavtalet för Birinapant med IGM Biosciences, värt upp till 350 MUSD.

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Medivir

8.99

▼ 0.04

-0.44%

Premium Plan required to unlock